Search

everythinglearnresearchcommunity

for

Search:↓

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Nanoparticle systems make cancer treatment less toxic.

ADM scaffolds help skin heal by promoting a healing-type immune response.

The study created a new type of microsphere that effectively regrows hair.

Activating autophagy in dogs with certain diseases improves their skin and hair.

Keratin-based hydrogels can be improved for medical use by adding PEG, making them more soluble and adjustable.

Blocking certain proteins on immune cells may help treat alopecia areata.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

The hydrogel effectively stops bleeding and heals diabetic wounds quickly.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

The system improved diabetic wound healing in rats.

A hydrogel made from pig fat helps wounds heal faster by regenerating skin fat cells.

Human amniotic stem cells can safely treat psoriasis-like skin in mice.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Autoimmune reactions may cause both alopecia areata and HAM.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

The new skin model can predict how chemicals might cause skin allergies.